Expect immediate selling pressure as pre-funded warrants are exercisable and the resale registration statement will be filed within 15 days. The massive overhang from the investment options (exercisable at $0.91, below the likely current trading price) will cap any upside. Monitor for stockholder approval meeting for Series A-1 options and any subsequent exercise activity. The company's tiny market cap makes this offering potentially existential for common equity value.
Price Chart
Executive Summary
Arcadia Biosciences (RKDA) raised approximately $4M in a private placement of pre-funded warrants and investment options to an institutional investor, representing ~200% of its $2M market cap. The offering includes pre-funded warrants for 3.88M shares immediately exercisable at $0.0001, plus Series A-1 and A-2 investment options for an additional 7.77M shares at $0.91, and placement agent options for 0.27M shares at $1.2875. Total potential dilution exceeds 11.65M shares, massively overhanging the current float.
Key Financial Metrics
Key Facts
- Gross proceeds of ~$4M from sale of pre-funded warrants and investment options to an institutional accredited investor
- Pre-funded warrants for 3,883,496 shares at $0.0001 exercise price, immediately exercisable and non-expiring
- Series A-1 investment options for 3,883,496 shares at $0.91, exercisable after stockholder approval, 5-year term
- Series A-2 investment options for 3,883,496 shares at $0.91, immediately exercisable, 24-month term from registration effective date
- Placement agent options for 271,845 shares at $1.2875 per share
- Total potential dilution of up to 11,650,488 shares (pre-funded + both series of options) plus placement agent options, against a $2M market cap
- Registration rights agreement requires filing within 15 days and best efforts for effectiveness within 45 days (75 days if full review)
- H.C. Wainwright & Co. acted as placement agent with 7% cash fee plus 1% management fee and expense reimbursement
Financial Impact
Offering size of ~$4M is 200% of current $2M market cap; potential dilution of up to 11.65M+ shares vs. current outstanding shares (not stated but implied to be very small given $2M cap and ~$1 stock price)
Risk Factors
- Extreme dilution from up to 11.65M+ new shares relative to current float
- Immediate exercisability of pre-funded warrants and Series A-2 options creates near-term selling overhang
- Registration statement filing within 15 days accelerates potential resale by the investor
- Stockholder approval requirement for Series A-1 options adds uncertainty but company is obligated to seek it
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-270560 |
| Document: 0001193125-26-270560-index.html | 0001193125-26-270560 |
| Document: 0001193125-26-270560.txt | 0001193125-26-270560 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 27d ago | SC 13G | $0.2800 | awaiting T+60 | — | $0.1520 (−45.71%) |
Sep 15, 2026 5w ago | 8-K | $0.4310 | awaiting T+60 | — | $0.1520 (−64.73%) |
Jul 9, 2026 15w ago | EFFECT | $0.6755 $0.2882 | ▲ +57.34% | ▲ +58.97% | $0.1520 (+77.50%) |
Jul 2, 2026 16w ago | 8-K | $0.7330 $0.3080 | ▼ −57.98% | ▼ −61.55% | $0.1520 (−79.26%) |
Jun 26, 2026 17w ago | S-3 | $0.7190 $0.4480 | ▲ +37.69% | ▲ +42.08% | $0.1520 (+78.86%) |
Jun 15, 2026 19w ago | 8-K | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1520 (+83.45%) |
Jun 12, 2026 19w ago | Press Release | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1520 (+83.45%) |
Jun 12, 2026 19w ago | Press Release | $0.9180 $0.4530 | ▲ +50.65% | ▲ +51.31% | $0.1520 (+83.44%) |
May 14, 2026 23w ago | 8-K | $0.9560 $0.6699 | ▲ +29.93% | ▲ +34.44% | $0.1520 (+84.10%) |
Apr 30, 2026 25w ago | 10-K/A | $1.12 $0.6300 | ▼ −43.75% | ▼ −46.82% | $0.1520 (−86.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers